Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)
- Status
- WITHDRAWN
- Phase
- PHASE2
Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- NA
A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery
- Status
- RECRUITING
- Phase
- PHASE3
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Status
- RECRUITING
- Phase
- PHASE3
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Volrustomig Priming Regimens Exploratory Phase II Platform Study
- Status
- RECRUITING
- Phase
- PHASE2